# Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK Inhibitors

> **NCT07526597** · PHASE2 · NOT_YET_RECRUITING · sponsor: **UNC Lineberger Comprehensive Cancer Center** · enrollment: 45 (estimated)

## Conditions studied

- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma

## Interventions

- **OTHER:** Discontinuing Bruton tyrosine kinase inhibitors (BTKi) therapy

## Key facts

- **NCT ID:** NCT07526597
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05
- **Primary completion:** 2032-06
- **Final completion:** 2032-06
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07526597

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07526597, "Study on Treatment Outcome Patterns for Patients With CLL After Discontinuation of BTK Inhibitors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07526597. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*